This project, is a collaboration of Prof. Yoram Weiss from Hadassah, Prof. Yechezkel Barenholz from HUJI and Prof. Goloubinoff from the University of Lausanne (Switzerland), aiming to treat Acute Respiratory...
Researcher/s: Prof. Yoram Weiss
Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19 infection is a rapidly deteriorating condition where components of the immune system react excessively and cause severe lung tissue damage,...
Researcher/s: Dr. Zvi Fridlender
The current test for SARS-CoV-2 virus requires several laborious steps as-well-as unique reagents that are at high demand these days. This project of Prof. Dana Wolf, in collaboration with Nir Fridman...
Researcher/s: Prof. Dana Wolf
Prof. Amnon Peled and his team have screened 1322 FDA-approved drugs for their ability to treat COVID-19 induced Pneumonia using a unique High Throughput Screening assay developed at Prof. Peled#39;s lab....
Researcher/s: Prof. Amnon Peled
Non-invasive ventilation is a useful tool in treating chronic to acute respiratory distress syndrome. Current solutions include masks, which often suffer leakage and are difficult to synchronize, and hoods...
Researcher/s: Dr. Elchanan Fried
Researcher/s: Dr. Tomer Batash
Prof. Rifaat Safadi and his team are developing an inhaled formulation that combines two FDA-approved drugs, which recruit and activate certain types of immune cells in patients with Acute Respiratory...
Researcher/s: Prof. Rifaat Safadi